For every drug or treatment out there, someone has had it tested on them to get it approved.
So what actually happens in clinical trials?
Some clinical drug trials can go on for months with participants receiving hundreds, or even thousands of dollars.
But they don’t all end well.
Dr Sophie Calabretto talks to Cosmos Magazine journalist Jacinta Bowler about why clinical trials are still the best process we have, how they can go wrong and why so many drugs fail to make it to market.
Listen to more episodes of The Science Briefing
Read science facts, not fiction...
There’s never been a more important time to explain the facts, cherish evidence-based knowledge and to showcase the latest scientific, technological and engineering breakthroughs. Cosmos is published by The Royal Institution of Australia, a charity dedicated to connecting people with the world of science. Financial contributions, however big or small, help us provide access to trusted science information at a time when the world needs it most. Please support us by making a donation or purchasing a subscription today.